Calidi Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10.56	9.59	1.95	0.37	2.14	0.42
Cash & Short-Term Investments	10.56	9.59	1.95	0.37	2.14	0.42
Cash Growth	823.97%	392.10%	423.93%	-82.59%	408.81%	-
Prepaid Expenses	0.6	0.54	2.25	0.31	0.5	0.09
Restricted Cash	-	0.1	0.1	0.1	0.1	-
Total Current Assets	11.49	10.23	4.3	0.79	2.74	0.51
Property, Plant & Equipment	3.43	3.8	5.34	1.09	0.59	0.72
Long-Term Deferred Charges	-	-	-	-	-	0.62
Other Long-Term Assets	0.14	0.15	0.37	0.73	0.07	-
Total Assets	15.06	14.18	10.02	2.6	3.39	1.85
Accounts Payable	1.21	2.07	2.88	2.27	0.62	0.97
Accrued Expenses	1.77	2.98	5.43	5.35	3.51	1.54
Short-Term Debt	-	0.47	0.53	3.46	5	4.94
Current Portion of Long-Term Debt	1.13	2.7	0.28	1.96	-	-
Current Portion of Leases	1.32	1.27	1.12	0.12	0.14	0.34
Other Current Liabilities	-	-	-	29.83	16.69	1.1
Total Current Liabilities	5.43	9.5	10.23	42.99	25.96	8.89
Long-Term Debt	0.6	0.6	2.06	-	-	6.37
Long-Term Leases	1.65	1.99	3.25	0.45	0.04	0.07
Other Long-Term Liabilities	0.09	0.13	2.71	-	-	-
Total Liabilities	7.77	12.21	18.25	43.44	26	15.33
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	133.67	123.28	91.38	19.93	13.32	11.95
Retained Earnings	-126.7	-121.72	-99.57	-70.36	-44.93	-34.44
Comprehensive Income & Other	-0.03	-0.03	-0.05	-0.01	-0	0.01
Total Common Equity	6.94	1.53	-8.24	-50.44	-31.61	-22.48
Minority Interest	0.36	0.43	-	-	-	-
Shareholders' Equity	7.3	1.97	-8.24	-40.84	-22.61	-13.48
Total Liabilities & Equity	15.06	14.18	10.02	2.6	3.39	1.85
Total Debt	4.71	7.04	7.24	5.99	5.18	11.72
Net Cash (Debt)	5.86	2.56	-5.29	-5.62	-3.04	-11.3
Net Cash Per Share	0.42	0.32	-3.14	-6.60	-1.54	-6.60
Filing Date Shares Outstanding	33.59	30.27	3.55	20.62	19.93	1.71
Total Common Shares Outstanding	33.59	22.56	3.55	20.62	19.93	1.71
Working Capital	6.06	0.73	-5.93	-42.2	-23.22	-8.38
Book Value Per Share	0.21	0.07	-2.32	-2.45	-1.59	-13.12
Tangible Book Value	6.94	1.53	-8.24	-50.44	-31.61	-22.48
Tangible Book Value Per Share	0.21	0.07	-2.32	-2.45	-1.59	-13.12
Machinery	1.66	1.64	1.66	1.1	0.68	0.46

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q